Dare We Say “Cure” in HER2 + Metastatic Breast Cancer? Complete responses. ctDNA negativity. Durable remission.This clip tackles the once-unthinkable question: Are some HER2-positive metastatic patients actually being cured? FacebookXRedditPinterestEmail You may also like Video Has HER2+ First-Line Treatment Officially Changed? – Dr. Neil Iyengar & Dr. Martin Dietrich 1 min read Video Why CLEOPATRA Became the Gold Standard in HER2+ Metastatic Breast Cancer 1 min read Video DESTINY-Breast09: 40 Months of PFS Changes Everything 1 min read Video Who Should Receive T-DXd + Pertuzumab in the First Line? 1 min read Video Is T-DXd Worth the Risk? Evaluating Benefit vs Toxicity 1 min read Video Treating to Progression vs. Clinical Flexibility: Finding the Balance 1 min read Recommended Videos Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago New First-Line Strategies in HER2+ Metastatic Breast Cancer – Dr. Mark Pegram & Dr. Carol Tweed 4 months ago Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? – Dr. Mark Pegram & Dr. Fengting Yan 4 months ago Cleopatra, DESTINY-Breast09 & What Comes Next – Drs. Bill Gradishar, Tarah Ballinger, & Megan Kruse 4 months ago
Video Has HER2+ First-Line Treatment Officially Changed? – Dr. Neil Iyengar & Dr. Martin Dietrich 1 min read
Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago
New First-Line Strategies in HER2+ Metastatic Breast Cancer – Dr. Mark Pegram & Dr. Carol Tweed 4 months ago
Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? – Dr. Mark Pegram & Dr. Fengting Yan 4 months ago
Cleopatra, DESTINY-Breast09 & What Comes Next – Drs. Bill Gradishar, Tarah Ballinger, & Megan Kruse 4 months ago